Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Biogen Idec
(NQ:
BIIB
)
218.06
-7.15 (-3.17%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Biogen Idec
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
37
38
Next >
Biogen CEO Says Alzheimer's Uptake 'Is Delayed,' But Shares Pop On Earnings Beat
October 20, 2021
Biogen's Alzheimer's drug is facing delayed uptake, but Q3 sales and earnings beat.
Via
Investor's Business Daily
Biogen Posts Just $300K Sales From Aduhelm In Q3, Though Earnings Beat Estimates
October 20, 2021
Biogen Inc (NASDAQ: BIIB) has posted Q3 adjusted EPS of $4.77 ahead of the consensus estimate of $4.11, but quarterly profit fell around 53% Y/Y to $329.2 million...
Via
Benzinga
Topics
Earnings
Exposures
Financial
The Daily Biotech Pulse: Novavax Retreats Amid Vaccine Issues, LumiraDx COVID Test Approved In India, Sesen Shines On Positive Bladder Cancer Review
October 20, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Novavax Shares React to Reports Of Manufacturing Issues With Its COVID-19...
Via
Benzinga
Earnings Outlook For Biogen
October 19, 2021
Biogen(NASDAQ:BIIB) is set to give its latest quarterly earnings report on Wednesday, 2021-10-20. Here's what investors need to know before the announcement. Analysts estimate...
Via
Benzinga
Ionis Stock Collapses On Another 'Misstep' As Biogen-Partnered ALS Drug Flops
October 18, 2021
Biogen and Ionis' approach to Lou Gehrig's disease missed its key goal.
Via
Investor's Business Daily
Analyst Ratings For Biogen
October 15, 2021
Biogen (NASDAQ:BIIB) has observed the following analyst ratings within the...
Via
Benzinga
Where Biogen Stands With Analysts
October 12, 2021
Within the last quarter, Biogen (NASDAQ:BIIB) has observed the following a...
Via
Benzinga
Earnings Scheduled For October 20, 2021
October 20, 2021
Companies Reporting Before The Bell • Canadian Pacific Railway (NYSE:CP) is expected to report quarterly earnings at $0.95 per share on revenue of $2.02 billion....
Via
Benzinga
Expert Ratings For Biogen
October 19, 2021
Over the past 3 months, 13 analysts have published their opinion on Biogen (NASDAQ:
Via
Benzinga
Analyst Ratings For Biogen
October 08, 2021
Over the past 3 months, 10 analysts have published their opinion on Biogen (NASDAQ:
Via
Benzinga
Analyst Ratings For Biogen
September 29, 2021
Biogen (NASDAQ:BIIB) has observed the following analyst ratings within the...
Via
Benzinga
Biogen's Antisense Candidate Flunks In Late-Stage Neurodegenerative Disorder Trial
October 18, 2021
Biogen Inc (NASDAQ: BIIB) has announced topline results from its Phase 3 VALOR study of tofersen (BIIB067), an investigational antisense drug for superoxide...
Via
Benzinga
The Week Ahead In Biotech (Oct. 18-23): J&J, Biogen Kickstart Big Pharma Earnings, Regeneron-Sanofi, Roche Await FDA Decisions And IPOs
October 18, 2021
Biotech stocks rebounded in the week ended Oct. 15, bouncing from third straight weekly losses. The strength came amid a broader market rally and some sector-specific news....
Via
Benzinga
Exposures
Product Safety
2 Top Healthcare Stocks That Could Be Bought Out in 2022
October 16, 2021
These two novel-drug makers could be top takeover targets next year.
Via
The Motley Fool
Exposures
COVID-19
Where Biogen Stands With Analysts
September 23, 2021
Within the last quarter, Biogen (NASDAQ:BIIB) has observed the following a...
Via
Benzinga
Crispr: A Fallen Angel In Gene Editing
October 16, 2021
As with most promising biotech companies, investors bid their prices up for CRSP based on its potential for early profits. When the payoff didn't occur on schedule, investors bailed out. Once it...
Via
Talk Markets
Why Humana Is Suing Biogen
October 09, 2021
Biogen continues to deal with the aftermath of allegedly paying co-pays for some Medicare patients.
Via
The Motley Fool
Could Biogen's Blockbuster Hopes for Alzheimer's Disease Drug Aduhelm Be Doomed?
October 08, 2021
Aduhelm could face yet another hurdle with reports of safety issues.
Via
The Motley Fool
3 Biotech Stocks That Could Make You Richer in October and Beyond
October 07, 2021
Three Motley Fool contributors think these biotech stocks should be big winners.
Via
The Motley Fool
Merck Keeps M&A Mode On With Mirati, Biogen, mRNA Companies On Radar: FT
October 06, 2021
Merck & Co Inc (NYSE: MRK) remains in a deal-hunting mode despite its recent $11.5 billion acquisition of Acceleron. Related: Merck Seals Acceleron Pharma Deal...
Via
Benzinga
Rising Oil Prices and Yields Makes Market Navigation More Complex
October 05, 2021
Bitcoin (/BTC) topped $50,000 this morning for the first since May, but traders may be more focused on oil prices and yields. Crude oil (/CL) is continuing its rise...
Via
Benzinga
Exposures
Fossil Fuels
See Why Perrigo Shares Are Moving Higher On Thursday
September 30, 2021
Over-the-counter drugs company Perrigo Company plc (NYSE:
Via
Benzinga
A Bit Of A Recovery
September 29, 2021
While Germany remains without a government, Japan has a new prime minister who will lead his party in the election this week.
Via
Talk Markets
Eisai, Biogen Initiate Rolling Submission For New Alzheimer's Drug
September 28, 2021
Eisai Co Ltd (OTC: ESALY) began its application process for lecanemab (BAN2401) for early Alzheimer's disease using an accelerated approval pathway. Lecanemab...
Via
Benzinga
The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive
September 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 27) Acceleron Pharma Inc. (...
Via
Benzinga
Benzinga's Bulls And Bears Of The Week: Apple, Bitcoin, Disney, Microsoft And More
September 25, 2021
Benzinga has examined the prospects for many investor favorite sto...
Via
Benzinga
Aduhelm's 'Blockbuster Potential' Is Underappreciated, Says Biogen Analyst
September 23, 2021
It's been about four months since Biogen, Inc. (NASDAQ:BII...
Via
Benzinga
Biogen Stock Pops, But D.C. Center Bans All — Not Just Aduhelm — Sales Reps
September 23, 2021
Biogen stock rose on a buy rating even as the Aduhelm controversy deepened.
Via
Investor's Business Daily
Benzinga's Top Ratings Upgrades, Downgrades For September 23, 2021
September 23, 2021
Upgrades Barclays upgraded the previous rating for Warner Music Group Corp (NASDAQ:
Via
Benzinga
Thinking About Buying Stock Or Options In Tesla, Ballard Power, Bloom Energy Or Biogen?
September 23, 2021
One of the most common questions traders have about stocks is “Why Is It Moving?” That’s why Benzinga created the Why Is It Moving, or WIIM, feature in...
Via
Benzinga
< Previous
1
2
...
25
26
27
28
29
30
31
32
33
...
37
38
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.